chr22-50720741-G-T

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001372044.2(SHANK3):​c.3094G>T​(p.Ala1032Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000772 in 1,230,590 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00052 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00081 ( 3 hom. )

Consequence

SHANK3
NM_001372044.2 missense

Scores

1
3
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 2.23
Variant links:
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017478019).
BP6
Variant 22-50720741-G-T is Benign according to our data. Variant chr22-50720741-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 252769.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=2}. Variant chr22-50720741-G-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000517 (76/146882) while in subpopulation NFE AF= 0.00102 (67/65984). AF 95% confidence interval is 0.000819. There are 0 homozygotes in gnomad4. There are 33 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 76 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SHANK3NM_001372044.2 linkc.3094G>T p.Ala1032Ser missense_variant Exon 24 of 25 NP_001358973.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SHANK3ENST00000262795.7 linkc.2509G>T p.Ala837Ser missense_variant Exon 20 of 22 5 ENSP00000489147.3 A0A0U1RQS4
SHANK3ENST00000445220.7 linkc.1561G>T p.Ala521Ser missense_variant Exon 11 of 13 5 A0A0U1RR93
SHANK3ENST00000664402.2 linkc.1051G>T p.Ala351Ser missense_variant Exon 5 of 7 ENSP00000499475.2 A0A590UJL3

Frequencies

GnomAD3 genomes
AF:
0.000518
AC:
76
AN:
146788
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000135
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000118
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00102
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000550
AC:
29
AN:
52690
Hom.:
0
AF XY:
0.000537
AC XY:
17
AN XY:
31632
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000129
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00104
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000806
AC:
874
AN:
1083708
Hom.:
3
Cov.:
33
AF XY:
0.000760
AC XY:
404
AN XY:
531676
show subpopulations
Gnomad4 AFR exome
AF:
0.0000517
Gnomad4 AMR exome
AF:
0.000147
Gnomad4 ASJ exome
AF:
0.000145
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000164
Gnomad4 FIN exome
AF:
0.000487
Gnomad4 NFE exome
AF:
0.000913
Gnomad4 OTH exome
AF:
0.000871
GnomAD4 genome
AF:
0.000517
AC:
76
AN:
146882
Hom.:
0
Cov.:
33
AF XY:
0.000461
AC XY:
33
AN XY:
71544
show subpopulations
Gnomad4 AFR
AF:
0.000146
Gnomad4 AMR
AF:
0.000135
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000118
Gnomad4 NFE
AF:
0.00102
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000476
ExAC
AF:
0.000206
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SHANK3: BS1 -

Nov 06, 2020
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 17999366) -

not specified Uncertain:1
Nov 06, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Phelan-McDermid syndrome;C3151380:Schizophrenia 15 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Inborn genetic diseases Benign:1
Aug 06, 2018
Ambry Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

SHANK3-related disorder Benign:1
Jun 26, 2024
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0053
.;T
Eigen
Benign
0.052
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.68
T;T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.017
T;T
MetaSVM
Benign
-0.79
T
PrimateAI
Pathogenic
0.92
D
REVEL
Benign
0.21
Sift4G
Benign
0.56
T;T
Vest4
0.091
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
gMVP
0.075

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs530255181; hg19: chr22-51159169; API